Novo Nordisk donates two months' worth of insulin to Ukraine

The Danish pharmaceutical company wants to ensure that supplies of essential medicines continue to reach Ukraine, and has therefore donated up to two months’ worth of insulin and hemophilia drugs to the country’s health authority.

Photo: Foto: Mik Eskestad/ERH

Novo Nordisk has decided to donate insulin and hemophilia drugs to last Ukraine’s health authority up to two months, the company reports on its website.

”We are doing all we can to maintain the supply of essential medicines to patients living with chronic diseases in Ukraine,” the website reads, also stating that the company has donated EUR 7.4m to Ukrainian refugees, with some funds allocated to Ukrainians with a connection to the firm, while EUR 700,000 of the amount was donated to the UN’s refugee agency, UNHCR.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs